.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
Daiichi Sankyo
Accenture
Queensland Health
UBS
Federal Trade Commission
US Army
Cerilliant
Colorcon

Generated: December 18, 2017

DrugPatentWatch Database Preview

BREATHTEK UBT FOR H-PYLORI Drug Profile

« Back to Dashboard

When do Breathtek Ubt For H-pylori patents expire, and when can generic versions of Breathtek Ubt For H-pylori launch?

Breathtek Ubt For H-pylori is a drug marketed by Otsuka America and is included in one NDA.

The generic ingredient in BREATHTEK UBT FOR H-PYLORI is urea c-13. There are thirty-three drug master file entries for this compound. Additional details are available on the urea c-13 profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka AmericaBREATHTEK UBT FOR H-PYLORIurea c-13FOR SOLUTION;ORAL020586-002May 10, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BREATHTEK UBT FOR H-PYLORI

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Otsuka AmericaBREATHTEK UBT FOR H-PYLORIurea c-13FOR SOLUTION;ORAL020586-002May 10, 2001► Subscribe► Subscribe
Otsuka AmericaBREATHTEK UBT FOR H-PYLORIurea c-13FOR SOLUTION;ORAL020586-002May 10, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Citi
QuintilesIMS
Chinese Patent Office
Julphar
Boehringer Ingelheim
Argus Health
Harvard Business School
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot